BUY Glenmark Pharmaceuticals — Rachna Vaidya, 27 Aug 2026

BUYGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byRachna VaidyaHorizon: Swing (≤2wk)27 Aug 2026via CNBC Awaaz.

Entry₹2,467.7Inferred

Target₹2,500

Total upside +1.31%

Stop lossNot given

Exit₹2,50028 Aug 2026, 2:25 pm

Target hit+1.31%0.00%upside left

Follow Rachna Vaidya for new calls(44% target hit, 27 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 2 active Swing calls on GLENMARK See 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Aug 2026

3 supporting1 neutral0 opposing

Supports the BUY call (3)

3 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Aug · today

Glenmark Pharmaceuticals Inc., USA has launched a new Calcium Gluconate Injection product in various strengths and vial sizes.

BSE · Company Update·21 Aug · 1w ago

Glenmark Pharmaceuticals has received approval from the U.S. FDA for its Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray.

BSE · Company Update·20 Aug · 1w ago

Neutral / worth noting (1)

Glenmark Pharma, Mastek, Triveni Engineering Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·28 Aug · today

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Rachna Vaidya

Every call and its outcome